CanActgx ® by Product

Available for both solid tumor and liquid biopsies, the CanActgx ® choice of reports includes

The CanAct® X reports and assays offer comprehensive highly multiplex gene panels that are involved in most cancers in addition the CanAct® X reports cover other cancer genetic attributes like microsatellite instability and tumor mutational burden. The CanAct® X reports and assays are available for liquid and solid tumor samples.

Solid tumor

CanAct X5.0

523 gene exome (all coding regions) DNA sequence analysis; including point and small indel mutations, amplification and deletions, MSI (Microsatellite İnstabilility) and TMB (Tumor Mutational Burden), 55 gene RNA transcript/translocation and exon skipping analysis

Catalog Numbers:
Solid Tumor:CNACT-701

Genes Covered

Liquid Biopsy

CanAct X5.0

523 gene exome (all coding regions) DNA sequence analysis; including point and small indel mutations, amplification and deletions, MSI (Microsatellite İnstabilility) and TMB (Tumor Mutational Burden), 23 gene rearrangement/translocation analysis

Catalog Numbers:
Liquid Biopsy:CNACT-702

Genes Coverd